Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2009;29:1858-1863
Published online before print September 24, 2009, doi: 10.1161/ATVBAHA.108.182519
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
29/11/1858    most recent
ATVBAHA.108.182519v1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Ino, J.
Right arrow Articles by Yoshida, M.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ino, J.
Right arrow Articles by Yoshida, M.
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2009;29:1858.)
© 2009 American Heart Association, Inc.


Integrative Physiology/Experimental Medicine

Dynamic Observation of Mechanically-Injured Mouse Femoral Artery Reveals an Antiinflammatory Effect of Renin Inhibitor

Jun Ino; Chiari Kojima; Mizuko Osaka; Kosaku Nitta; Masayuki Yoshida

From the Life Science and Bioethics Research Center (J.I., C.K., M.O., M.Y.), Tokyo Medical and Dental University; and the Department of Internal Medicine IV (J.I., C.K., K.N.), Tokyo Women’s Medical University, Japan.

Correspondence to Masayuki Yoshida, MD, Life Science and Bioethics Research Center, Tokyo Medical and Dental University, 1-5-45 Yushima Bldg D-9, Bunkyo-ku, Tokyo 113-8519 Japan. E-mail masa.vasc{at}tmd.ac.jp

Objective— The renin-angiotensin-aldosterone system (RAS) plays a central role in atherosclerosis. To investigate the effects of a direct renin inhibitor aliskiren on vascular inflammation, we conducted leukocyte adhesion assays in vivo and in vitro using a novel real-time imaging system.

Methods and Results— Aliskiren (10 mg/kg/d) or PBS was administered to C57BL/6 mice (6–7 weeks of age; Oriental Yeast, Tokyo, Japan) for 2 weeks via an osmotic pump. Blood pressure was not significantly changed in the 2 groups throughout the experimental period. A perivascular cuff injury was then introduced to the femoral artery and real-time intravital microscopic observation was conducted 24 hours after injury. The number of adherent leukocytes was elevated in the injured mice without aliskiren (43.8±9.3/10–2 mm2), whereas that was significantly reduced in the mice with aliskiren (18.4±4.4, P<0.05). Treatment of human umbilical vein endothelial cells (HUVECs) with aliskiren significantly reduced the adhesion of THP-1 cells to TNF-{alpha}–activated HUVECs (P<0.05). Interestingly, TNF-{alpha}–induced renin activity and angiotensin II production in HUVECs were also blunted by aliskiren. Furthermore, exogenous renin and angiotensin II abrogated the aliskiren-mediated reduction of THP-1 cell adhesion to HUVECs.

Conclusions— Our in vivo and in vitro findings indicate a pivotal role for renin inhibition in vascular inflammation independent of blood pressure.

This study indicates a pivotal role for renin inhibition in vascular inflammation independent of blood pressure in vivo and in vitro. Our findings also suggest a novel antiinflammatory role for aliskiren.


Key Words: atherosclerosis • renin-angiotensin-aldosterone system • renin inhibition • endothelium